Hyperspectral imaging
Hyperspectral imaging is an intervention with 8 clinical trials. Currently 2 active trials ongoing.
Success Metrics
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
0.0%
0 of 2 finished
100.0%
2 ended early
2
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions
Endothelial Dysfunction for Prognosis In Patients With preeClampSia
Intraoperative EXamination Using MAChine-learning-based HYperspectral for diagNosis & Autonomous Anatomy Assessment
HSI for Intersegmental Plane Identification During Sublobar Pulmonary Resections
Tissue Characterization With Hyperspectral Imaging (HSI)
Clinical Trials (8)
A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions
Endothelial Dysfunction for Prognosis In Patients With preeClampSia
Intraoperative EXamination Using MAChine-learning-based HYperspectral for diagNosis & Autonomous Anatomy Assessment
HSI for Intersegmental Plane Identification During Sublobar Pulmonary Resections
Tissue Characterization With Hyperspectral Imaging (HSI)
Intraoperative Hyperspectral Imaging in Gastrointestinal Anastomoses
Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging
Hyperspectral Imaging for Neoplasm Early Stage Detection
All 8 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 8